Treatment results in aplastic anemia trials need to be analyzed separately for pediatric and adult populations [4] (multiple letters)

Blood

Volumn 94, Issue 5, 1999, Pages 1833-1834

  Reddy, V ^a   Khan, S ^a   Wingard, J R ^a   Mehta, P ^a   Marsh, J ^a   Schrezenmeier, H ^a   Marin, P ^a   Ilhan, O ^a   McCann, S ^a   Socie, G ^a   Tichelli, A ^a   Passweg, J ^a   Hows, J ^a   Raghavachar, A ^a   Locascuilli, A ^a   Bacigalupo, A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 6; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TREATMENT OUTCOME;

EID: 0033198455     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.5.1833.417a40d_1833_1834     Document Type: Letter

References (0)